Multi-omics and artificial intelligence for precision drug discovery and potential clinical applications
Yuqing Liu, Kun Zhu, Weijun Peng, Zhaoqian Liu, Xiaoyuan Mao · 2026
Read Multi-omics and artificial intelligence for precision drug discovery and potential clinical applications by Yuqing Liu, Kun Zhu, Weijun Peng, Zhaoqian Liu, Xiaoyuan Mao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13230739.txt.
Description
Yuqing Liu and colleagues review in 2026 how combining many layers of biological data with artificial intelligence could speed drug discovery. Genome, gene activity, protein, and chemical data together reveal disease workings that single data types miss. Deep learning models can find hidden patterns in those large mixed datasets and predict promising compounds.
Uses run from finding new targets and reusing old drugs to designing fresh molecules and checking safety early. Examples in cancer, brain disease, and heart disease show the approach already at work. Hard problems remain, including matching data formats, repeating results, and guarding against biased algorithms. Trial design may also sharpen when likely responders are picked in advance.
Catalog record
| CREATOR | Yuqing Liu, Kun Zhu, Weijun Peng, Zhaoqian Liu, Xiaoyuan Mao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 141 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |